Combinatorial Drug Therapy for ALS Motor Neuron Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for amyotrophic lateral sclerosis (ALS) are limited, with no clear diagnostic test and few effective pharmacologic therapies available, and existing treatments primarily focus on symptom management rather than disease modification.
Innovation Solution
The development of novel combinatorial therapies using drug combinations such as acamprosate, baclofen, cinacalcet, mexiletine, sulfisoxazole, and torasemide, either alone or in combination with riluzole, to treat ALS and related disorders, which have shown protective effects against glutamate toxicity and potential to delay disease progression and increase survival.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for ALS are used, then symptom management is provided, but disease modification is not achieved and survival is limited
Solution Approach 1:
The patent combines multiple drugs with different mechanisms of action into a single composition. The composition includes riluzole (modifies disease progression), edaravone (antioxidant protection), and baclofen (symptom management), allowing simultaneous achievement of disease modification and symptom relief, thereby improving both treatment effectiveness and survival time
Solution Approach 2:
The treatment composition functions as a composite therapeutic agent, integrating multiple pharmacological compounds that target different pathological pathways in ALS. This composite approach addresses the limitation of single-drug therapies by providing multifaceted protection against motor neuron degeneration while extending survival
2Reliability
If single drug therapies are used, then treatment simplicity is maintained, but therapeutic effect is insufficient
Solution Approach 1:
Multiple drugs are merged into a single pharmaceutical composition that can be administered together. The composition integrates riluzole, edaravone, and baclofen in specific formulations, providing enhanced therapeutic effects while simplifying administration compared to separate dosing regimens
Solution Approach 2:
The treatment composition serves multiple therapeutic functions simultaneously: disease progression modification, oxidative stress reduction, and symptom management. This multi-functional approach increases therapeutic effectiveness without requiring multiple separate treatment protocols
Data Source
AI summary
The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.